Statement by the Press Secretary on S. 1878
On Friday, September 30, 2016, the President signed into law:
S. 1878, the “Advancing Hope Act of 2016,” which modifies the Food and Drug Administration priority review voucher program for rare pediatric diseases and extends authority for the program through December 31, 2016.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
